The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.90
Bid: 17.92
Ask: 18.00
Change: -0.50 (-2.72%)
Spread: 0.08 (0.446%)
Open: 18.20
High: 18.20
Low: 17.90
Prev. Close: 18.40
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM, Move to Main Market and Placing

22 Apr 2015 16:45

RNS Number : 0446L
Nanoco Group PLC
22 April 2015
 

 

For immediate release

22 April 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Result of General Meeting, Move to Main Market

and Placing to raise £20 million gross

 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that all resolutions were duly passed at its General Meeting held earlier today in connection with the Company's proposed move from AIM to the Main Market of the London Stock Exchange and the Placing announced on 31 March 2015.

 

Following the outcome of the General Meeting, the Company will now proceed with the proposed move to the Main Market and the Placing to raise gross proceeds of £20 million.

A summary of the votes cast on the Resolutions put to Shareholders at the General Meeting is shown below:

 

Resolutions

For

Against

Withheld

Number

%

Number

%

Number

1

THAT, conditionally upon Admission, the New Articles of Association (as defined in the Circular) be approved and adopted as the new articles of association of the Company in substitution for, and to the exclusion of, the existing articles of association of the Company.

 

140,776,175

 

99.95

72,957

0.05

578

2

THAT, conditionally upon the passing of Resolution 1 and in addition to the authority conferred on the Directors at the annual general meeting of the Company held on 11 December 2014, the Directors be generally and unconditionally authorised, in accordance with section 551 of the Companies Act 2006, to allot up to 19,047,619 Ordinary Shares in aggregate in the capital of the Company, such authority to expire at the end of 31 July 2015.

 

140,776,753

 

99.94

80,400

0.06

0

3

THAT, conditionally upon the passing of Resolutions 1 and 2 and in addition to the authority conferred on the Directors at the annual general meeting of the Company held on 11 December 2014, the Directors be given power to allot up to 19,047,619 Ordinary Shares for cash pursuant to the authority referred to in Resolution 2 other than on a pro-rata basis to shareholders as if section 561 of the Companies Act 2006 did not apply, such authority to expire at the end of 31 July 2015.

 

140,761,553

 

99.86

 

201,664

0.14

15,200

 

The issued share capital of the Company on the date of the meeting was 217,330,383 ordinary shares of 10 pence each ("Ordinary Shares").

In accordance with the Disclosure Rules and Transparency Rules, a copy of the Resolutions proposed and passed at the General Meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM and will also be available for inspection at www.nanocotechnologies.com.

Notification of the Company's intention to de-list from AIM has been submitted to the London Stock Exchange. It is expected that the last day of dealings in the Ordinary Shares on AIM will occur on 30 April 2015.

Applications will shortly be made to the Official List and to the London Stock Exchange for 236,378,002 Ordinary Shares, fully paid and conditional upon Admission, to be admitted to listing on the premium segment of the Official List and to be admitted to trading on the Main Market. It is expected that Admission of the 236,378,002 Ordinary Shares will occur at 8.00 a.m. on 1 May 2015.

Completion of the Placing and Admission remains subject to certain conditions. A further announcement will be made in due course.

All capitalised terms in this announcement have the meaning given to them in the Circular, unless otherwise defined herein.

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Mark Sullivan, Interim Chief Financial Officer

Canaccord Genuity - Nomad, Sponsor and Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUOVRVKASUAR
Date   Source Headline
9th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return
7th Dec 20233:23 pmRNSResult of AGM
7th Dec 20237:00 amRNSAGM Statement & Trading Update
15th Nov 20237:00 amRNSFirst ever commercial production order
13th Nov 20234:28 pmRNS2023 Annual Report and Notice of AGM
7th Nov 20237:00 amRNSJoint Development Agreement with Asian Customer
2nd Nov 20232:18 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSUnaudited Preliminary Results
10th Oct 20237:00 amRNSNotice of Results
3rd Oct 20234:32 pmRNSForeign Currency Hedge of Litigation Settlement
14th Aug 20233:58 pmRNSResult of Meeting
8th Aug 20237:00 amRNSTrading Update
7th Aug 20237:00 amRNSGlass Lewis recommends to support Nanoco’s Board
2nd Aug 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.